| | | | | segments using pre-filled injectables have been |
| Pre-Filled Syringes and Related Systems: World | | | | growing in revenue, but which will expand fastest in |
| Market Outlook 2010-2025 | | | | future? What are the therapeutic and commercial |
| Report Detailshow will rising demand and technological | | | | trends to watch? How will the global market for |
| developments create opportunities? | | | | pre-filled syringe-type products perform from 2010 to |
| The market for pre-filled syringes has achieved | | | | 2025? Our report answers such questions, providing |
| growth in recent years. In 2009, an estimated 2 billion | | | | the information that you need. |
| pre-filled syringe units were sold and the market for | | | | The range of pre-filled syringes and related products |
| that technology was estimated to be worth up to $2.5 | | | | has broadened into many areas, including: |
| billion. There is a trend towards pre-filled drug injection | | | | * Vaccines |
| systems, away from vials/ampules, for both new and | | | | * Anti-coagulants |
| existing products. Examples are filled glass and plastic | | | | * Anti-infectives |
| syringes, pens and low-volume auto-injection devices, | | | | * Anti-inflammatory agents |
| including refills. That sector has shown growth of | | | | * Haematological agents |
| 10-15% in recent years, forming one of the | | | | * Multiple sclerosis therapies |
| fastest-expanding sectors in the pharmaceutical | | | | * Hormone therapies |
| industry. In our new report, we predict that the pre-filled | | | | * Obstetric agents |
| drug delivery market will grow steadily from 2010, as | | | | * Cancer therapies |
| the number of products launched in pre-filled injectable | | | | * Pain relievers. |
| forms increases. Medical professionals, patients and | | | | The pharmaceutical industry accepts pre-filled drug |
| other stakeholders see the benefits of that | | | | technology as a proven market and the format of |
| more-convenient system, raising demand at the | | | | choice for many parentally-administered drugs. |
| expense of older formats. ( ) | | | | Because a product's delivery system can affect |
| Pre-Filled Syringes and Related Systems: World | | | | patient compliance – influencing therapeutic |
| Market Outlook 2010-2025 shows how a range of | | | | outcomes, cost-effectiveness and brand image – |
| therapeutic agents – vaccines, insulins, analogues | | | | easier-to-use devices can confer higher sales and |
| and many other biologicals – drive growth in that | | | | market share. Our new report shows how |
| sector. Combined with new pre-filled drug delivery | | | | partnerships between companies will be crucial when |
| systems and healthcare safety and cost-saving | | | | developing and harnessing pre-filled injection |
| initiatives, the market for pre-filled syringes and similar | | | | technologies. |
| devices will expand steadily. All the therapeutic | | | | |